Institute of Social and Preventive Medicine

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

Julia Bohlius, Sven Trelle, Olaf Weingart et al.

2008 · 38 Zit.

Premature Discontinuation of Randomized Trials in Critical and Emergency Care

Stefan Schandelmaier, Erik von Elm, John J. You et al.

2015 · 31 Zit.

Machine learning approaches to evaluate heterogeneous treatment effects in randomized controlled trials: a scoping review

Kosuke Inoue, Motohiko Adomi, Orestis Efthimiou et al.

2024 · 23 Zit.

PROTEUS: A Prospective RCT Evaluating Use of AI in Stress Echocardiography

Ross Upton, Ashley P. Akerman, Thomas H. Marwick et al.

2024 · 17 Zit.

Personalized solutions for menopause through artificial intelligence: Are we there yet?

Zayne Milena Roa‐Díaz, Taulant Muka, Oscar H. Franco

2019 · 8 Zit.

Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents

Thomy Tonia, Guido Schwarzer, Julia Bohlius

2013 · 5 Zit.

Influence of Clinical and Economical Factors on the Expert Rating of Appropriateness of Preoperative Use of Recombinant Erythropoietin in Elective Orthopedic Surgery Patients

Patrick Taffé, Bernard Burnand, Vincent Wietlisbach et al.

2004 · 5 Zit.

InfoKids+: A Validation Study of a Pediatric Acuity Risk Stratification Algorithm

Carl Starvaggi, Sophie Affentranger, Noelie Lengeler et al.

2025 · 0 Zit.

Artificial Intelligence and Innovation in Oral Health Care Sciences: A Conceptual Review

Marco Dettori, Demetrio Lamloum, Peter Lingström et al.

2025 · 0 Zit.